Growth hormone treatment in children with short stature born small for gestational age: 5-Year results of a randomized, double-blind, dose-response trial

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 9, 1999, Pages 3064-3070

  Sas, Theo ^a   De Waal, Wouter ^a   Mulder, Paul ^b   Houdijk, Mieke ^c   Jansen, Maarten ^d   Reeser, Maarten ^e   Hokken Koelega, Anita ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e JULIANA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

AGE; ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

EID: 0033305332     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.9.3064     Document Type: Article

References (44)

1. Natural growth in children born small for gestational age with and without catch-up growth
2. Children born small for gestational age: Do they catch-up?
3. Histoire naturelle des retards de croissance a debut intra-uterin
4. Adult height in children with prepubertal short stature secondary to intra uterine growth retardation
5. Growth in full-term small-for-gestational-age infants: From birth to final height
6. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation
7. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation
8. Investigation of growth hormone secretion in patients with intrauterine growth retardation
9. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intra-uterine growth retardation
10. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational children
11. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age
12. Increased proportion of circulating non-22-kilo-dalton growth hormone isoforms in short children: A possible mechanism for growth failure
13. Effect of human growth hormone treatment for 1 to 7 years on the growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome, and other complaints
14. Acute and long-term responses to hGH in children with idiopathic small-of-dates dwarfism
15. Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?
16. Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation
17. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth retarded children
18. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset
19. Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation
20. High-dose growth hormone treatment of short children born small for gestational age
21. Growth hormone treatment of short children born small-for-gestational-age: The Nordic Multi-centre trial
22. Growth hormone treatment of short children born small for gestational age: Reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years
23. Intrauterine growth of liveborn caucasian infants at sea level: Standard obtained from measurements of infants born between 25 and 44 weeks of gestation
24. Growth diagrams 1980, Netherlands. Third nation-wide survey
25. Prepubertal height velocity references over a wide age range
26. Longitudinal standards for height, weight-height, height velocity and stages of puberty
27. The methods of auxological anthropometry
28. Twenty-four-hour growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation
29. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis GH deficiency
30. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome
31. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation
32. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency
33. Growth hormone treatment of short children born small for gestational age
34. The natural history of the Silver-Russell syndrome: A longitudinal study of thirty-nine cases
35. Adolescent growth and pubertal progression in the Silver-Russell syndrome
36. Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: Results from KIGS (Kabi international growth study), including the first report on final height
37. Final height in children with IUGR receiving GH treatment
38. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome
39. Insulin resistance in short children with intrauterine growth retardation
40. Type 2 (non-insulin- dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
41. Self-concept before and after two years of growth hormone treatment in intrauterine growth-retarded children